Rungby has received personal honoraria for consulting, lectures, and/or for advisory board participation within the last 36 months from AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Janssen-Cilag, Merck Sharp & Dohme, Novo Nordisk, and Sanofi-Aventis and has received unrestricted research grants from Novo Nordisk and Merck
Mechano-Growth Factor: an important cog or a loose screw in the repair machinery
Pharmacological therapies for autism spectrum disorder: a review
It can be challenging to achieve and sustain significant weight loss through diet and exercise alone
Kim ER, Park JS, Kim JH, Oh JY, Oh IJ, Choi DH et al (2022) A GLP-1/GLP-2 receptor dual agonist to treat NASH: targeting the gut-liver axis and microbiome
The molecule is the same, but the delivery format, concentration, and preparation requirements differ significantly